KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Total Debt (2016 - 2025)

Historic Total Debt for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $598.2 million.

  • Edwards Lifesciences' Total Debt rose 11.72% to $598.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $598.2 million, marking a year-over-year increase of 11.72%. This contributed to the annual value of $597.7 million for FY2024, which is 11.73% up from last year.
  • Per Edwards Lifesciences' latest filing, its Total Debt stood at $598.2 million for Q3 2025, which was up 11.72% from $598.0 million recorded in Q2 2025.
  • Edwards Lifesciences' Total Debt's 5-year high stood at $598.2 million during Q3 2025, with a 5-year trough of $595.2 million in Q1 2021.
  • Moreover, its 5-year median value for Total Debt was $596.7 million (2023), whereas its average is $596.7 million.
  • As far as peak fluctuations go, Edwards Lifesciences' Total Debt grew by 11.77% in 2021, and later increased by 10.05% in 2025.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Total Debt stood at $595.7 million in 2021, then grew by 0.1% to $596.3 million in 2022, then increased by 0.12% to $597.0 million in 2023, then increased by 0.12% to $597.7 million in 2024, then rose by 0.08% to $598.2 million in 2025.
  • Its last three reported values are $598.2 million in Q3 2025, $598.0 million for Q2 2025, and $597.8 million during Q1 2025.